I think the delay is correct. If there is a link to the No vote,...

First 16 Last

Share
Profile

Follow
rustys33

1,858 Posts.

534

02/05/22

17:34

Post #: 61153618
Share
Originally posted by TerribleTadpole: ↑

I've already requested the shareholder register, and transferred the funds in payment for it today.

Rather than rush ahead, I'm more inclined to wait for a number of reasons:
We are already drafting our letter in public. Both Pfizer and Resapp will be aware of what we are planning to say to the shareholders. If we send first then they have the final right of reply to any of our arguments in their booklet and any associated statements.
If we send before the meeting has been announced then we will be asking holders to vote before they are able to vote. There is a risk they will "cool off" and not bother, or simply forget about the whole thing by the time voting opens.
There are several ways that the vote might never get to happen: Pfizer could withdraw the offer, the independent expert might find the offer is not in the best interests of shareholders, a superior offer could emerge that Pfizer are not prepared to match. If anything like this were to happen I think I'l like to put the extra money into Resapp shares rather than a mailout.

I suggest that we wait until we're certain we need to proceed, and until we've seen the booklet. That way we get the final right of reply, unless the company decides to send an update out of course...

Expand

I think the delay is correct. If there is a link to the No vote, then it should be a matter of going and voting straight away. The letter should serve two purposes

1) convince people to vote No
2) get people to vote

A clear call to action is needed and I think it's best if the vote is already in play ....if feasible
RAP Price at posting: 11.3¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

AW1

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

LGM

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

GRE

Greentech finds lithium trend across 5.5 km at WA's Kobe South

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”